FIELD: pharmaceutical industry. SUBSTANCE: treatment and prevention of I and II types of diabetes as well as hyperglycemic, hyperinsulinemic, and low insulin-sensitivity conditions in animals involves administration of pharmaceutical composition and nutritive mix containing fatty acid analogs having general formula CH3-[CH2]m-[x1-CH2]n-COOR. EFFECT: enabled effective action on disease pathogenesis due to lipid metabolism correction. 31 cl, 8 dwg, 10 tbl, 19 ex
| Title |
Year |
Author |
Number |
| ANALOGS OF FATTY ACIDS, METHOD FOR THEIR PREPARING, METHOD FOR TREATMENT OF DISEASES, PHARMACEUTICAL COMPOSITION AND NUTRIENT COMPOSITION COMPRISING ANALOGS THEREOF AND METHOD FOR PROVIDING BODY MASS LOSS |
2001 |
- Berge Rol'F
- Sjudnes Lejv K.
- Songstad Jon
|
RU2288215C2 |
| COMPOSITION CONTAINING VEGETABLE OR COD-LIVER OIL AND COMPOUNDS WHICH CONTAIN NON-OXIDISING STRUCTURAL ELEMENTS OF FATTY ACIDS |
2005 |
|
RU2388490C2 |
| COMPOSITION CONTAINING PROTEIN MATERIAL AND COMPOUNDS WHICH CONTAIN UNOXIDISABLE STRUCTURAL ELEMENTS OF FATTY ACIDS |
2005 |
|
RU2394598C2 |
| NEW ANALOGUES OF FATTY ACIDS FOR TREATMENT OF OBESITY, HYPERTENSION AND HEPATIC ADIPOSE INFILTRATION |
1999 |
|
RU2219920C2 |
| THERAPEUTIC AGENT CONTAINING COMBINED USE OF COMBINATION OF DPP-IV INHIBITOR AND OTHER THERAPEUTIC AGENT FOR TREATING DIABETES |
2009 |
- Goto Moritaka
- Jamashita Satoko
- Nakaja Kejzo
- Tomoguri Tetsushi
- Ishida Tsutomu
- Fuchigami Masakhiro
|
RU2523552C2 |
| APPLICATION OF PIRASOLE DERIVATIVE FOR OBTAINMENT OF MEDICINE FOR PREVENTION AND TREATMENT OF DYSLIPIDEMIA AND DISEASES RELATED TO DYSLIPIDEMIA AND/OR OBESITY |
2004 |
- Aron Mishel'
- Bensaid Mokhammed
- Ehrber Zhan-Mark
- Kheshmati Khassan Massud
- Zhaniak Filip
|
RU2357731C2 |
| METHOD FOR TREATMENT OF SUGAR DIABETES INCLUDING STATES ASSOCIATED WITH SUGAR DIABETES, AND SUGAR DIABETES COMPLICATIONS |
2003 |
- Pritchard Khajdn P.
- Vasan Kishor M.
- Lukich Tat'Jana
|
RU2334518C2 |
| COMPOSITION OF COPEPODS FAT, PREPARATION CONTAINING SUCH FAT COMPOSITION, USING IT FOR REDUCING VISCERAL FAT STORAGE, IMPROVING GLUCOSE TOLERANCE, PREVENTING OR TREATING OBESITY-RELATED DISEASES AND DISORDERS |
2010 |
- Ro Jan
- Rerstad Gunnar
- Tande Kurt Stejnar
|
RU2539921C2 |
| THERAPEUTIC TREATMENT OF METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR POTENTIAL DIABETES |
2008 |
|
RU2467743C2 |
| N-[2-HYDROXY-3(1-PIPERIDINYL)-PROPOXY]-PYRIDINE-1-OXYDE-3- CARBOXYIMIDOYL CHLORIDE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND TREATMENT METHOD |
2000 |
- Kjurti Marija
- Biro Katalin
- Nad' Karoj
- Iregdi Laslo
- Chakai Zita
- Sil'Bereki Jene
- Mod'Eroshi Tamash
- Terek Magdol'Na
- Komaromi Andrash
- Marvan'Osh Ehde
- Barabash Mikhaj
- Kardosh Mikhajne
- Nad' Zol'Tan
- Koran'I Laslo
- Nad' Melinda
|
RU2250901C2 |
